Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis

BACKGROUND: Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. CASE PRESENTATION: We report three cases of successful intensive treatment by Impella of FM without any complications. In all cases, impairment of microcirculation as measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Takayuki, Iida, Mitsuru, Uchiyama, Masateru, Shimokawa, Tomoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004069/
https://www.ncbi.nlm.nih.gov/pubmed/35414115
http://dx.doi.org/10.1186/s13019-022-01821-x
_version_ 1784686212374593536
author Hori, Takayuki
Iida, Mitsuru
Uchiyama, Masateru
Shimokawa, Tomoki
author_facet Hori, Takayuki
Iida, Mitsuru
Uchiyama, Masateru
Shimokawa, Tomoki
author_sort Hori, Takayuki
collection PubMed
description BACKGROUND: Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. CASE PRESENTATION: We report three cases of successful intensive treatment by Impella of FM without any complications. In all cases, impairment of microcirculation as measured by blood lactate level and the hemodynamic value as indicated by cardiac index were improved within 24–48 h and 7 days after Impella implantation, respectively. Interestingly, our data also suggested that treatment by Impella CP or 5.0 may lead to faster recovery of microcirculation and cardiac function than treatment by Impella 2.5. CONCLUSION: Our findings demonstrate that the appropriate selection of Impella devices guided by body surface area measurements may help to improve clinical outcomes of severe heart failure including FM.
format Online
Article
Text
id pubmed-9004069
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90040692022-04-13 Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis Hori, Takayuki Iida, Mitsuru Uchiyama, Masateru Shimokawa, Tomoki J Cardiothorac Surg Case Report BACKGROUND: Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. CASE PRESENTATION: We report three cases of successful intensive treatment by Impella of FM without any complications. In all cases, impairment of microcirculation as measured by blood lactate level and the hemodynamic value as indicated by cardiac index were improved within 24–48 h and 7 days after Impella implantation, respectively. Interestingly, our data also suggested that treatment by Impella CP or 5.0 may lead to faster recovery of microcirculation and cardiac function than treatment by Impella 2.5. CONCLUSION: Our findings demonstrate that the appropriate selection of Impella devices guided by body surface area measurements may help to improve clinical outcomes of severe heart failure including FM. BioMed Central 2022-04-12 /pmc/articles/PMC9004069/ /pubmed/35414115 http://dx.doi.org/10.1186/s13019-022-01821-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Hori, Takayuki
Iida, Mitsuru
Uchiyama, Masateru
Shimokawa, Tomoki
Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title_full Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title_fullStr Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title_full_unstemmed Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title_short Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
title_sort successful cases of percutaneous left ventricular assist device “impella” to fulminant myocarditis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004069/
https://www.ncbi.nlm.nih.gov/pubmed/35414115
http://dx.doi.org/10.1186/s13019-022-01821-x
work_keys_str_mv AT horitakayuki successfulcasesofpercutaneousleftventricularassistdeviceimpellatofulminantmyocarditis
AT iidamitsuru successfulcasesofpercutaneousleftventricularassistdeviceimpellatofulminantmyocarditis
AT uchiyamamasateru successfulcasesofpercutaneousleftventricularassistdeviceimpellatofulminantmyocarditis
AT shimokawatomoki successfulcasesofpercutaneousleftventricularassistdeviceimpellatofulminantmyocarditis

Ejemplares similares